Dexilant (Cardinal Health)


Welcome to the PulseAid listing for the Dexilant drug offered from Cardinal Health. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: dexlansoprazole
SUBSTANCE NAME: DEXLANSOPRAZOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, DELAYED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-04-12
END MARKETING DATE: 0000-00-00


Dexilant HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDexilant from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 60(mg/1)
START MARKETING DATE: 2010-04-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-5154_7ca8988e-3f57-4a73-8b72-f339d1246669
PRODUCT NDC: 55154-5154
APPLICATION NUMBER: NDA022287

Other DEXLANSOPRAZOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthDexilant
Physicians Total Care, Inc.Dexilant
Takeda Pharmaceuticals America, Inc.Dexilant